User menu

Genes coding for tumor-antigens recognized by cytolytic T-lymphocytes

Bibliographic reference Van Pel, Aline ; van der Bruggen, Pierre ; Coulie, Pierre ; Brichard, Vincent G. ; Lethe, Bernard ; et. al. Genes coding for tumor-antigens recognized by cytolytic T-lymphocytes. In: Immunological Reviews, Vol. 145, p. 229-250 (1995)
Permanent URL http://hdl.handle.net/2078.1/47931
  1. Anichini A., Int. J. Cancer, 36, 683 (1985)
  2. Anichini A., J. Exp. Med., 111 (1993)
  3. Boël Pascale, Wildmann Claude, Sensi Maria Luisa, Brasseur Robert, Renauld Jean-Christophe, Coulie Pierre, Boon Thierry, van der Bruggen Pierre, BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes, 10.1016/s1074-7613(95)80053-0
  4. Boon T., Adv. Cancer Res., 58, 177 (1992)
  5. Boon T., Cancer Surveys, 13, 23 (1992)
  6. Brasseur K., Int. J. Cancer, 52, 839 (1992)
  7. Brichard V., The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas, 10.1084/jem.178.2.489
  8. Brichard V. G., Eur. J. Immunol., 25, 664 (1995)
  9. Celis E., Proc. Natl. Acad. Sci. USA, 91, 2105 (1994)
  10. Cepko Constance L., Roberts Bryan E., Mulligan Richard C., Construction and applications of a highly transmissible murine retrovirus shuttle vector, 10.1016/0092-8674(84)90440-9
  11. Cerundolo V., Eur. J. Immunol., 21, 2069 (1991)
  12. Chambost H., Br. J. Haematol., 84, 524 (1993)
  13. Coulie P. G., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas, 10.1084/jem.180.1.35
  14. Coulie P. G., Int. J. Cancer, 5th (1992)
  15. Coulie P. G., Proc. Natl. Acad. Sci. USA (1995)
  16. Cox A. L., Science, 264, 716 (1994)
  17. Crowley N. J., Cancer Res., 50, 492 (1990)
  18. Bergeyck V., Eur. J. Immunol, 24, 2203 (1994)
  19. De Plaen Etienne, Traversari Catia, Gaforio José J., Szikora Jean-Pierre, De Smet Charles, Brasseur Francis, van der Bruggen Pierre, Lethé Bernard, Lurquin Christophe, Chomez Patrick, De Backer Olivier, Boon Thierry, Arden Karen, Cavenee Webster, Brasseur Robert, Structure, chromosomal localization, and expression of 12 genes of the MAGE family, 10.1007/bf01246677
  20. Plaen E., Proc. Natl. Acad Sci. USA, 85, 2274 (1988)
  21. De Smet C., Lurquin C., van der Bruggen P., De Plaen E., Brasseur F., Boon T., Sequence and expression pattern of the human MAGE2 gene, 10.1007/bf00188615
  22. Dranoff G., Proc. Natl. Acad. Sci. USA, 90, 3539 (1993)
  23. Engelhard V. H., Structure of Peptides Associated with Class I and Class II MHC Molecules, 10.1146/annurev.immunol.12.1.181
  24. Espevik Terje, Nissen-Meyer Jon, A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes, 10.1016/0022-1759(86)90322-4
  25. Gansbacher B., Cancer Res., 50, 7820 (1990)
  26. Gaugler B., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes, 10.1084/jem.179.3.921
  27. HAAS GILBERT G., D'CRUZ OSMOND J., DE BAULT LAWRENCE E., Distribution of Human Leukocyte Antigen-ABC and -D/DR Antigens in the Unfixed Human Testis, 10.1111/j.1600-0897.1988.tb00234.x
  28. Herin M., Int. J. Cancer, 39, 390 (1987)
  29. Hewitt H B, Blake E R, Walder A S, A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin, 10.1038/bjc.1976.37
  30. Hill A.V.S., Nature, 360 (1992)
  31. Hock H., Proc. Natl. Acad Sci. USA, 90, 2774 (1993)
  32. Hom S. S., J Immunother, 10, 133 (1991)
  33. Houbiers J. G. A., Eur. J. Immunol., 23, 2072 (1993)
  34. Ioannides C. G., FASEB J., 6, 2711 (1992)
  35. Kawakami Y., Proc. Natl. Acad. Sci. USA, 91, 3515 (1994)
  36. Kawakami Y., Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes, 10.1084/jem.180.1.347
  37. Kawakami Y., J. Immunol., 148, 638 (1992)
  38. Klein E., J. Natl. Cancer Inst., 32, 547 (1964)
  39. Knuth A., Proc. Natl. Acad. Sci. USA, 81, 3511 (1954)
  40. Kripke M. L., J. Natl. Cancer Inst., 53, 1333 (1974)
  41. Lehmann F., Eur. J. Immunol., 25, 340 (1995)
  42. Lethe B., Eur. J. Immunol., 22, 2283 (1992)
  43. Livingston P. O., Int. J. Cancer, 24, 34 (1979)
  44. Lurquin Christophe, Van Pel Aline, Mariamé Bernard, De Plaen Etienne, Szikora Jean-Pierre, Janssens Catherine, Reddehase Matthias J., Lejeune Joseph, Boon Thierry, Structure of the gene of tum− transplantation antigen P91A: The mutated exon encodes a peptide recognized with Ld by cytolytic T cells, 10.1016/0092-8674(89)90844-1
  45. Mandelboim Ofer, Berke Gideon, Fridkin Mati, Feldman Michael, Eisenstein Miriam, Eisenbach Lea, CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma, 10.1038/369067a0
  46. Maruyama Kei, Usami Mihoko, Aizawa Takako, Yoshikawa Kazuaki, A novel brain-specific mRNA encoding nuclear protein (necdin) expressed in neurally differentiated embryonal carcinoma cells, 10.1016/0006-291x(91)91812-q
  47. Miescher S., Int. J. Cancer, 42, 659 (1958)
  48. Miescher S., J. Immunol., 138, 4004 (1987)
  49. Miller A. D., Proc. Natl. Acad. Sci. USA, 80, 4709 (1983)
  50. Mukherji B., Clonal analysis of cytotoxic T cell response against human melanoma, 10.1084/jem.158.1.240
  51. Neefjes J. J., Eur. J. Immunol, 18, 801 (1988)
  52. Patard J.-J., Int. J. Cancer, 64, 60 (1995)
  53. Patel B. T., Int. J. Cancer, 51, 878 (1992)
  54. Prehn R. T., J. Natl. Cancer Inst., 18, 769 (1957)
  55. Rimoldi D., Int. J. Cancer, 54, 527 (1993)
  56. Robbins P. F., Cancer Res., 54, 3124 (1994)
  57. Romero P., J. Exp. Med. (1995)
  58. Rosenfeld Melissa A., Yoshimura Kunihiko, Trapnell Bruce C., Yoneyama Koichi, Rosenthal Eugene R., Dalemans Wilfried, Fukayama Masashi, Bargon Joachim, Stier Larue E., Stratford-Perricaudet Leslie, Perricaudet Michel, Guggino William B., Pavirani Andrea, Lecocq Jean-Pierre, Crystal Ronald G., In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium, 10.1016/0092-8674(92)90213-v
  59. Ruppert Jörg, Sidney John, Celis Esteban, Kubo Ralph T., Grey Howard M., Sette Alessandro, Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules, 10.1016/0092-8674(93)90472-3
  60. Schendel D. J., J. Immunol, 151, 4209 (1993)
  61. Seed B., Proc. Natl. Acad. Sci. USA, 84, 3365 (1987)
  62. Sibille C., Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide, 10.1084/jem.172.1.35
  63. Slingluff C. L., Cancer Res., 54, 2731 (1994)
  64. Slovin S. F., J. Immunol, 137, 3042 (1986)
  65. TAYLOR J, TRIMARCHI C, WEINBERG R, LANGUET B, GUILLERMIN F, DESMETTRE P, PAOLETTI E, Efficacy studies on a canarypox-rabies recombinant virus, 10.1016/0264-410x(91)90152-v
  66. Taylor Jill, Weinberg Randall, Tartaglia James, Richardson Christopher, Alkhatib Ghalib, Briedis Dalius, Appel Max, Norton Elizabeth, Paoletti Enzo, Nonreplicating viral vectors as potential vaccines: Recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins, 10.1016/0042-6822(92)90321-f
  67. Topalian S. L., Proc. Natl. Acad. Sci. USA, 91, 9461 (1994)
  68. Townsend S. E., Science, 259, 36S (1993)
  69. Traversari C., A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E, 10.1084/jem.176.5.1453
  70. Traversari Catia, van der Bruggen Pierre, Van den Eynde Benoît, Hainaut Philippe, Lemoine Carine, Ohta Nobuyoshi, Old Lloyd, Boon Thierry, Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes, 10.1007/bf00185107
  71. Uyttenhove C., Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression, 10.1084/jem.157.3.1040
  72. Eynde B., Int. J. Cancer, 44, 634 (1989)
  73. Van den Eynde B., The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice, 10.1084/jem.173.6.1373
  74. Eynde B., Eur. J. Immunol., 24, 2740 (1994)
  75. Eynde B., J. Exp. Med (1995)
  76. Bruggen P., Eur. J. Immunol., 24, 3038 (1994)
  77. Bruggen P., Eur. J. Immunol., 24, 2134 (1994)
  78. Bruggen P., Science, 254, 1643 (1991)
  79. Van Pel A., Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis, 10.1084/jem.157.6.1992
  80. Vanky E, Int. J. Cancer, 29, 547 (1982)
  81. Viret C, Eur. J. Immunol, 23, 141 (1993)
  82. Vose B. M., Int. J. Cancer, 29, 33 (1982)
  83. Weynanls R., Int. J. Cancer, 56, 826 (1994)
  84. Wolfel T., Int. J. Cancer, 55, 237 (1993)
  85. Wolfel T., Int. J. Cancer, 54, 636 (1993)
  86. Wolfel T., Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens, 10.1084/jem.170.3.797
  87. Wolfel T., Eur. J. Immunol., 24, 759 (1994)
  88. Yasumura S., Cancer Res., 53, 1461 (1993)